Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Hazard Rate01:11

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
Estimating Population Standard Deviation01:26

Estimating Population Standard Deviation

When the population standard deviation is unknown and the sample size is large, the sample standard deviation s is commonly used as a point estimate of σ. However, it can sometimes under or overestimate the population standard deviation. To overcome this drawback, confidence intervals are determined to estimate population parameters and eliminate any calculation bias accurately. However, this only applies to random samples from normally distributed populations. Knowing the sample mean and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

VEGF Is a Stronger Predictor of Depressive Symptoms than Other Inflammation Markers in People with HIV on Antiretroviral Therapy.

Viruses·2026
Same author

Design and Analysis of Randomized Clinical Trials With Average Hazard: Practical Guidance and Tools for Implementation.

Statistics in medicine·2026
Same author

Nonparametric estimation of the total treatment effect with multiple outcomes in the presence of terminal events.

Biometrics·2026
Same author

Bereaved Caregiver Perspectives on Quality of Care at the End of Life Among Adolescents and Young Adults with Cancer.

Journal of palliative medicine·2026
Same author

Longitudinal Patterns of Symptoms in Patients Undergoing Chemotherapy: A Secondary Analysis of a Cluster Randomized Clinical Trial.

JAMA network open·2026
Same author

Randomized clinical trial of an Acceptance and Commitment Therapy telehealth intervention ('REVITALIZE') to reduce fatigue interference in women with advanced ovarian cancer on PARP inhibitors: study protocol.

BMC cancer·2026
Same journal

Individualized dynamic latent factor model for multi-resolutional data with application to mobile health.

Biometrika·2026
Same journal

Functional principal component analysis forsparse censored data.

Biometrika·2026
Same journal

Finding distributions that differ, with false discovery rate control.

Biometrika·2026
Same journal

Sequential Gibbs posteriors with applications to principal component analysis.

Biometrika·2026
Same journal

Comparing causal parameters with many treatments and positivity violations.

Biometrika·2026
Same journal

Leveraging External Data for Testing Experimental Therapies with Biomarker Interactions in Randomized Clinical Trials.

Biometrika·2026
See all related articles

Related Experiment Video

Updated: May 17, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Calibrating parametric subject-specific risk estimation.

T Cai1, L Tian, Hajime Uno

  • 1Department of Biostatistics , Harvard University , Boston, Massachusetts 02115 , U.S.A. tcai@hsph.harvard.edu.

Biometrika
|October 11, 2012
PubMed
Summary
This summary is machine-generated.

This study introduces a new method to calibrate individual disease risk scores, improving predictions for patient mortality. The approach enhances evidence-based medicine by providing more accurate risk assessments for clinical decision-making.

More Related Videos

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Related Experiment Videos

Last Updated: May 17, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Area of Science:

  • Biostatistics
  • Clinical Epidemiology
  • Medical Informatics

Background:

  • Risk index systems guide disease prevention and management in evidence-based medicine.
  • Current risk scoring schemes often rely on simplified parametric models.
  • Global model validation methods like receiver operating characteristic analysis exist but lack subject-level calibration.

Purpose of the Study:

  • To propose and validate a subject-level calibration method for risk index systems.
  • To develop point and interval estimation procedures for t-year mortality rates conditional on parametric risk scores.
  • To improve the accuracy of individual risk predictions for clinical events.

Main Methods:

  • Development of point and interval estimation procedures for conditional mortality rates.
  • Calibration of existing parametric risk scores at the individual patient level.
  • Application and illustration using data from a large clinical trial involving post-myocardial infarction patients.

Main Results:

  • The proposed method allows for subject-level calibration of risk index systems.
  • Point and interval estimates for t-year mortality rates were successfully developed.
  • The methodology was demonstrated effectively on a real-world clinical dataset.

Conclusions:

  • The developed method offers a more precise way to calibrate individual risk scores.
  • This subject-level calibration enhances the utility of risk index systems in clinical practice.
  • The findings contribute to more accurate disease risk prediction and personalized medicine.